BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16940531)

  • 1. Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.
    Mosoian A; Teixeira A; High AA; Christian RE; Hunt DF; Shabanowitz J; Liu X; Klotman M
    J Virol; 2006 Sep; 80(18):9200-6. PubMed ID: 16940531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.
    Teixeira A; Yen B; Gusella GL; Thomas AG; Mullen MP; Aberg J; Chen X; Hoshida Y; van Bakel H; Schadt E; Basler CF; García-Sastre A; Mosoian A
    J Infect Dis; 2015 May; 211(9):1467-75. PubMed ID: 25404520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
    Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
    PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prothymosin-alpha on HIV-1 target cells.
    Mosoian A; Teixeira A; Burns CS; Khitrov G; Zhang W; Gusella L; Klotman P; Klotman M
    Ann N Y Acad Sci; 2007 Sep; 1112():269-85. PubMed ID: 17600282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction.
    Mosoian A; Teixeira A; Burns CS; Sander LE; Gusella GL; He C; Blander JM; Klotman P; Klotman ME
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10178-83. PubMed ID: 20479248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.
    Chang TL; François F; Mosoian A; Klotman ME
    J Virol; 2003 Jun; 77(12):6777-84. PubMed ID: 12767998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication.
    Leith JG; Copeland KF; McKay PJ; Bienzle D; Richards CD; Rosenthal KL
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1553-61. PubMed ID: 10580406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific.
    Copeland KF; McKay PJ; Rosenthal KL
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1321-6. PubMed ID: 8573388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell supernatants of HIV type 1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes.
    Copeland KF; Leith JG; McKay PJ; Rosenthal KL
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):71-7. PubMed ID: 8989429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.
    Mackewicz CE; Blackbourn DJ; Levy JA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2308-12. PubMed ID: 7534418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines.
    Mosoian A; Teixeira A; Caron E; Piwoz J; Klotman ME
    Viral Immunol; 2000; 13(4):481-95. PubMed ID: 11192295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8
    Passos LSA; Jha PK; Becker-Greene D; Blaser MC; Romero D; Lupieri A; Sukhova GK; Libby P; Singh SA; Dutra WO; Aikawa M; Levine RA; Nunes MCP; Aikawa E
    Circulation; 2022 Feb; 145(7):531-548. PubMed ID: 35157519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element.
    Copeland KF; McKay PJ; Rosenthal KL
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):143-8. PubMed ID: 8834464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.
    Chen CH; Weinhold KJ; Bartlett JA; Bolognesi DP; Greenberg ML
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1079-86. PubMed ID: 8312050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation.
    Skopeliti M; Kratzer U; Altenberend F; Panayotou G; Kalbacher H; Stevanovic S; Voelter W; Tsitsilonis OE
    Proteomics; 2007 Jun; 7(11):1814-24. PubMed ID: 17474146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible expression of the deltaNGFr/F12Nef fusion protein as a new tool for anti-human immunodeficiency virus type 1 gene therapy.
    Muratori C; Schiavoni I; Melucci-Vigo G; Olivetta E; Santarcangelo AC; Pugliese K; Verani P; Federico M
    Hum Gene Ther; 2002 Sep; 13(14):1751-66. PubMed ID: 12396627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothymosin alpha functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro.
    Orre RS; Cotter MA; Subramanian C; Robertson ES
    J Biol Chem; 2001 Jan; 276(3):1794-9. PubMed ID: 11036085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
    Schafer EA; Venkatachari NJ; Ayyavoo V
    Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors.
    Copeland KF; McKay PJ; Newton JJ; Rosenthal KL
    Clin Exp Immunol; 1998 Oct; 114(1):87-93. PubMed ID: 9764608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.